-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Industry News] "Layoffs", "salary cuts" and "adjustments" are becoming high-frequency words in the news of pharmaceutical companies
.
The wave of layoffs in pharmaceutical companies will continue in 2022! For example, in April 2022, the cardiovascular product line of Weijian Pharmaceutical will notify layoffs and compensation Give N+1, and leave immediately after getting the compensation
.
If the regional manager does not leave, he needs to be demoted and work as a representative
.
Fosun Pharma has also been laid off on a large scale, and even some large areas will basically be laid off; I have been unable to get on, so I had to disband a group of tumor representatives previously dug from foreign companies.
.
.
According to statistics, as of April 19, the 2021 annual reports disclosed by nearly 200 domestic listed pharmaceutical companies showed that the total number of employees of about 50 companies appeared.
Declines to varying degrees
.
Companies that have significantly reduced staff include both pharmaceutical distribution companies such as Shanghai Pharmaceuticals, and biopharmaceutical companies such as Sunshine Guojian
.
In addition, multinational pharmaceutical companies are also reporting layoffs in 2022.
For
example
, on April 9 Kaleido Biosciences announced that it will immediately stop all the company's business, and lay off all employees, without leaving one, and directly dissolve in place.
.
.
Novartis announced that it will integrate multiple business units to streamline the structure, promote growth and save costs.
As part of this restructuring plan, Novartis will lay off thousands of employees worldwide
.
There are constant news and plans for layoffs, but there are also pharmaceutical companies that are aggressively "recruiting", and the number of employees in CXO companies has grown significantly
.
For example, WuXi PharmaTech is a past one .
A listed pharmaceutical company with a large scale of annual employee expansion
.
Data shows that in 2021, the number of WuXi AppTec employees will increase by 8,501 compared with the previous year, and the total number of employees will reach 34,912
.
According to the public information of Kanglong Chemical, as of the end of 2021, the total number of employees of Kanglong Chemical reached 14,900, of which 13,500 were R&D, production technology and clinical service personnel, accounting for 90.
16% of the company's total number, an increase of 3,628 compared with the end of 2020
.
With the advancement of the internationalization strategy, Pharmaron has a total of 10 operating entities in the UK and the US, with more than 1,100 employees
.
According to the data, at the end of 2021, Tigermed had a total of 8,326 employees, an increase of 38% from 6,032 at the end of the previous year
.
Asymchem's 2021 annual report shows that the company continues to strengthen the introduction and training of senior talents, firmly grasp and adhere to the talent introduction strategy, and realize the continuous expansion of the talent echelon by combining internal training and external introduction.
As of the end of this reporting period , the company has 7,126 employees, 149 people with experience in overseas multinational companies, 3,381 people in R&D and analysis, accounting for 47.
45%
.
Statistics show that the total number of employees of Asymchem and Proton shares will also increase by more than 1,000 in 2021.
Relatively small CXO companies, such as Zhaoyan New Drug (603127.
SH) and Medicilon (688202.
SH), will add new employees.
The number of employees has also reached hundreds.
Compared with 2020, the total number of employees has increased by more than 40% year-on-year
.
The data shows that behind the continuous growth of the talent team, the performance growth of CXO companies has become more and more obvious
.
The financial report data shows that the year-on-year growth rate of operating income and net profit of leading CXO companies in 2021 will almost be more than 40%
.
For example, WuXi AppTec's revenue in 2021 will increase by 38.
5% year-on-year to 22.
902 billion yuan; net profit will increase by 72.
19% year-on-year to 5.
097 billion yuan
.
Kanglong Chemical's revenue in 2021 will increase by 45% year-on-year to 7.
444 billion yuan; net profit will increase by 41.
68% year-on-year to 1.
661 billion yuan
.
Tigermed's revenue in 2021 will increase by 63.
32% year-on-year to 5.
214 billion yuan; net profit will increase by 64.
26% year-on-year to 2.
874 billion yuan,
etc.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
The wave of layoffs in pharmaceutical companies will continue in 2022! For example, in April 2022, the cardiovascular product line of Weijian Pharmaceutical will notify layoffs and compensation Give N+1, and leave immediately after getting the compensation
.
If the regional manager does not leave, he needs to be demoted and work as a representative
.
Fosun Pharma has also been laid off on a large scale, and even some large areas will basically be laid off; I have been unable to get on, so I had to disband a group of tumor representatives previously dug from foreign companies.
.
.
According to statistics, as of April 19, the 2021 annual reports disclosed by nearly 200 domestic listed pharmaceutical companies showed that the total number of employees of about 50 companies appeared.
Declines to varying degrees
.
Companies that have significantly reduced staff include both pharmaceutical distribution companies such as Shanghai Pharmaceuticals, and biopharmaceutical companies such as Sunshine Guojian
.
In addition, multinational pharmaceutical companies are also reporting layoffs in 2022.
For
example
, on April 9 Kaleido Biosciences announced that it will immediately stop all the company's business, and lay off all employees, without leaving one, and directly dissolve in place.
.
.
Novartis announced that it will integrate multiple business units to streamline the structure, promote growth and save costs.
As part of this restructuring plan, Novartis will lay off thousands of employees worldwide
.
There are constant news and plans for layoffs, but there are also pharmaceutical companies that are aggressively "recruiting", and the number of employees in CXO companies has grown significantly
.
For example, WuXi PharmaTech is a past one .
A listed pharmaceutical company with a large scale of annual employee expansion
.
Data shows that in 2021, the number of WuXi AppTec employees will increase by 8,501 compared with the previous year, and the total number of employees will reach 34,912
.
According to the public information of Kanglong Chemical, as of the end of 2021, the total number of employees of Kanglong Chemical reached 14,900, of which 13,500 were R&D, production technology and clinical service personnel, accounting for 90.
16% of the company's total number, an increase of 3,628 compared with the end of 2020
.
With the advancement of the internationalization strategy, Pharmaron has a total of 10 operating entities in the UK and the US, with more than 1,100 employees
.
According to the data, at the end of 2021, Tigermed had a total of 8,326 employees, an increase of 38% from 6,032 at the end of the previous year
.
Asymchem's 2021 annual report shows that the company continues to strengthen the introduction and training of senior talents, firmly grasp and adhere to the talent introduction strategy, and realize the continuous expansion of the talent echelon by combining internal training and external introduction.
As of the end of this reporting period , the company has 7,126 employees, 149 people with experience in overseas multinational companies, 3,381 people in R&D and analysis, accounting for 47.
45%
.
Statistics show that the total number of employees of Asymchem and Proton shares will also increase by more than 1,000 in 2021.
Relatively small CXO companies, such as Zhaoyan New Drug (603127.
SH) and Medicilon (688202.
SH), will add new employees.
The number of employees has also reached hundreds.
Compared with 2020, the total number of employees has increased by more than 40% year-on-year
.
The data shows that behind the continuous growth of the talent team, the performance growth of CXO companies has become more and more obvious
.
The financial report data shows that the year-on-year growth rate of operating income and net profit of leading CXO companies in 2021 will almost be more than 40%
.
For example, WuXi AppTec's revenue in 2021 will increase by 38.
5% year-on-year to 22.
902 billion yuan; net profit will increase by 72.
19% year-on-year to 5.
097 billion yuan
.
Kanglong Chemical's revenue in 2021 will increase by 45% year-on-year to 7.
444 billion yuan; net profit will increase by 41.
68% year-on-year to 1.
661 billion yuan
.
Tigermed's revenue in 2021 will increase by 63.
32% year-on-year to 5.
214 billion yuan; net profit will increase by 64.
26% year-on-year to 2.
874 billion yuan,
etc.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
